Abstract:Pharmacometric approaches achieves higher power to detect a drug effect compared to traditional statistical hypothesis tests. Known drawbacks come from the model building process where multiple testing and model misspecification are major causes for type I error inflation. IMA is a new approach using mixture models and the likelihood ratio test (LRT) to test for drug effect. It previously showed type I error control and unbiased drug estimates in the context of two-arms balanced designs using real placebo data, in comparison to the standard approach (STD). The aim of this study was to extend the assessment of IMA and STD regarding type I error, power, and bias in the drug effect estimates under various types of model misspecification, with or without LRT calibration. Two classical statistical approaches, t-test and Mixed-Effect Model Repeated Measure (MMRM), were also added to the comparison. The focus was a simulation study where the extent of the model misspecification is known, using a response model with or without drug effect as motivating example in two sample size scenarios. The IMA performances were overall not impacted by the sample size or the LRT calibration, contrary to STD which had better type I error results with the larger sample size and calibrated LRT. In terms of power STD required LRT calibration to outperform IMA. T-test and MMRM had both controlled type I error. The t-test had a lower power than both STD and IMA while MMRM had power predictions similar to IMA. IMA and STD had similarly unbiased drug effect estimates, with few exceptions. IMA showed again encouraging performances (type I error control and unbiased drug estimates) and presented reasonable power predictions. The IMA performances were overall more robust towards model mis-specification compared to STD. IMA confirmed its status of promising NLMEM-based approach for hypothesis testing of the drug effect and could be used in the future, after further evaluations, as primary analysis in confirmatory trials.

Closed-form REML estimators and sample size determination for mixed effects models for repeated measures under monotone missingness

Meta‐Analysis of Studies with Missing Data

An Efficient Multiple Imputation Algorithm for Control-Based and Delta-Adjusted Pattern Mixture Models using SAS

Mixed Model Applications to the Analysis of Repeated Measures Data in Clinical Trials

Improving the mixed model for repeated measures to robustly increase precision in randomized trials

Small sample adjustment for inference without assuming orthogonality in a mixed model for repeated measures analysis

A Comparison of REML and Bayesian Estimation of Variance Components for Unbalanced One-way Random Effects Models With Small Sample Sizes

Sample Size Determination and Re‐estimation for Matched Pair Designs with Multiple Binary Endpoints

Comparison of Software Algorithms for Calculating Reml Wald Type Confidence Limits for the Between-Group Variance Component in A Small Sample One-Way Random Effects Model Example

Assessment of non-linear mixed effects model-based approaches to test for drug effect using simulated data: type I error and power properties

Adaptive sample size re-estimation in MRMC studies

Using Targeted Maximum Likelihood Estimation to Estimate Treatment Effect with Longitudinal Continuous or Binary Data: A Systematic Evaluation of 28 Diabetes Clinical Trials

Restricted maximum likelihood estimation in generalized linear mixed models

On sample size determination for restricted mean survival time-based tests in randomized clinical trials

Model-based optimal randomization procedure for treatment–covariate interaction tests

On inference of control-based imputation for analysis of repeated binary outcomes with missing data

Estimation of treatment policy estimands for continuous outcomes using off treatment sequential multiple imputation

Markov-Restricted Analysis of Randomized Trials with Non-Monotone Missing Binary Outcomes

A Quick and Accurate Method for the Estimation of Covariate Effects Based on Empirical Bayes Estimates in Mixed-Effects Modeling: Correction of Bias Due to Shrinkage.

Linear Mixed-Effects Models for Dependent Data: Power and Accuracy in Parameter Estimation.

Inference for Repeated Measures Models under Heteroscedasticity